Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8

9 clinical trials · Condition

Sort:Newest first Oldest first

◉ Watch Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8

Record	Firm	Date
Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adenocarcinoma (NCT05041153)	M.D. Anderson Cancer Center	2022-02-14
Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer (NCT04660760)	Academic and Community Cancer Research United	2021-06-16
Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers (NCT04460937)	National Cancer Institute (NCI)	2021-04-09
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors (NCT04771520)	M.D. Anderson Cancer Center	2021-01-20
Pembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal Cancer (NCT04522336)	M.D. Anderson Cancer Center	2020-09-16
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers (NCT04221893)	University of California, San Francisco	2020-08-07
Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer (NCT04220827)	M.D. Anderson Cancer Center	2019-12-06
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study (NCT03707574)	National Cancer Institute (NCI)	2019-07-16
IRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Cancer (NCT03918499)	City of Hope Medical Center	2019-04-19

Track Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8 automatically

Every clearance here is in the API, with alerts when new ones post.